News
Patients, scientists at odds over breast cancer drug A day later, she was standing outside a Food and Drug Administration office building in Silver Spring, Maryland, where a panel of six experts was getting ready for an unusual hearing: two days of discussion and a vote on the fate of
Avastin,
... read moreSmith Says Roche Has `Strong Case' in Avastin Hearing June 28 (Bloomberg) -- Justin Smith, an analyst at MF Global UK Ltd., discusses the outlook for the US Food and Drug Administration's Oncologic Drugs advisory panel hearing on Roche Holding AG's breast-cancer drug
Avastin. The panel heard from more
... read moreStudies Show Lucentis Effective At Treating Diabetic Eye Condition An estimated 75000 new cases of diabetic macular edema develop each year in the US Lucentis, and the cancer drug
Avastin, also sold by Roche, work by inhibiting a protein involved in blood-vessel formation. Lucentis is meant to be injected into eyes
... read more
.jpg)
No comments:
Post a Comment